Cochrane Hypertension

Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.

🆕 @cochrane.org Review update 🆕

Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....

In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

#SystematicReview

Cochrane logo on a blue background with the text 'Cochrane aligns reporting formats for diverse types of reviews.' Below, a stack of books on a table in a library setting conveys a scholarly tone.

Clearer, more consistent Cochrane reviews are coming.

From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.

🔗 www.cochrane.org/about-us/new...

Webinar: Dr Jack Wilkinson - Too good to be true? Spotting problematic trials in systematic reviews To register, CLICK HERE Systematic reviews of randomized controlled trials (RCTs) aim to include all eligible

Too good to be true? Spotting problematic trials in systematic reviews | Online
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...

Getting involved in health research reviews: a course for the public | Online
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...

📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵

ICYMI - Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing

Also check out our complementary #deprescribing resources to reduce potentially inappropriate medications found here:
deprescribing.org/resources/de...

🚨ICYMI - Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing

🆕 We've published a new Cochrane #SystematicReview protocol:

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...

SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

YouTube video by Therapeutics Initiative Dr. Josh Levin: Physical activity compared to drugs for important clinical outcomes.

🚨 ICYMI - TI #BestEvidence webinar:

Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes
ti.ubc.ca/drugevidence24

#DrugEvidence24 #exercise #MedEd

YouTube video by Therapeutics Initiative Dr. James (Jim) Wright: Debunking some of the hype In hypertension

ICYMI: #BestEvidence webinar recording

Debunking some of the hype in #hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives

⏰ chronotherapy
💊 first line tx
🎯 BP targets
⚠️ tx efficacy + safety

#DrugEvidence24 #MedEd #medsafety

🚨Updated Cochrane #SystematicReview:

Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

#CochraneEvidence #bloodpressure #deprescribing

YouTube video by Therapeutics Initiative Dr. Josh Levin: Exercise prescriptions - Evidence and clinical applications

🧵 #ExercisePrescriptions

1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾‍♀️🏊🏾‍♂️ 🚶🏾‍♂️

👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...

#Exercise #prescribing #ExerciseRx

🆕 Cochrane #SystematicReview 🆕

Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....

#CochraneEvidence #blogshot #bloodpressure

🆕 Cochrane #SystematicReview 🆕

Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....

#CochraneEvidence #blogshot #bloodpressure

ICYMI - Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

🚨ICYMI - Cochrane #SystematicReview

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2

#CochraneEvidence #Blogshot

YouTube video by Therapeutics Initiative Dr. James (Jim) Wright: Debunking some of the hype In hypertension

#BestEvidence webinar recording

Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives:

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

#drugevidence24 #meded #medsafety

🎺 Cochrane #SystematicReview 🚨

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn

#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social

🎺 Cochrane #SystematicReview 🚨

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence #Blogshot

🆕 Cochrane #SystematicReview 🎺

Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...

#CochraneEvidence

🆕 #BestEvidence webinar recording

Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on #antihypertensives:

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

#drugevidence24 #meded #medsafety

ICYMI - For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯

Our #Cochrane review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...

#SystematicReview #hypertension #medsky #pharmsky

ICYMI - hypertension #systematicreview

Our Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn

#researchsky #prescribing #HighBloodPressure #medsky

🎺 For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯

Our #Cochrane systematic review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...

#SystematicReview #hypertension